Your browser doesn't support javascript.
loading
Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza.
Vanderven, Hillary A; Wentworth, Deborah N; Han, Win Min; Peck, Heidi; Barr, Ian G; Davey, Richard T; Beigel, John H; Dwyer, Dominic E; Jain, Mamta K; Angus, Brian; Brandt, Christian T; Mykietiuk, Analia; Law, Matthew G; Neaton, James D; Kent, Stephen J.
Afiliação
  • Vanderven HA; Biomedicine, College of Public Health, Medical and Veterinary Sciences, and.
  • Wentworth DN; Australian Institute of Tropical Health and Medicine, James Cook University, Douglas, Queensland, Australia.
  • Han WM; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
  • Peck H; Divison of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Barr IG; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia..
  • Davey RT; WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.
  • Beigel JH; WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.
  • Dwyer DE; National Institute of Allergy and Infectious Disease (NIAID), Bethesda, Maryland, USA.
  • Jain MK; National Institute of Allergy and Infectious Disease (NIAID), Bethesda, Maryland, USA.
  • Angus B; New South Wales Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, Australia.
  • Brandt CT; UT Southwestern Medical Center, Dallas, Texas, USA.
  • Mykietiuk A; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Law MG; Department of Infectious Diseases, Zealand University Hospital Roskilde, Denmark.
  • Neaton JD; Instituto Médico Platense, Buenos Aires, Argentina.
  • Kent SJ; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia..
JCI Insight ; 8(14)2023 07 24.
Article em En | MEDLINE | ID: mdl-37289541

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Influenza Humana Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Influenza Humana Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article